USA – NEW YORK Trends and Developments Contributed by: Ejim Achi, Shaun Levor, Serena Shi and Alexander Mandel, Greenberg Traurig, LLP
islation may further expand disclosure requirements and increase regulatory scrutiny, potentially extending timelines for larger or more complex transactions. For New York healthcare deals, this is a core execution consideration that should be incorporated into front- end deal planning. Summary The central theme for 2026 is resilience. The M&A market is grappling with geopolitical instability, ener - gy-price risk, trade-policy uncertainty and the possi - bility that inflation expectations may remain less set - tled than many had hoped coming into the year. Each of those issues can affect valuation, financing, timing and the allocation of risk between buyers and sellers. Each also requires more deliberate planning at the front end of a transaction process.
Even so, there continues to be optimism that 2026 can still be a robust year for M&A. There is a large backlog of assets in search of routes to liquidity, sig - nificant amounts of capital that need to be deployed and a continuing strategic imperative for businesses to evolve through acquisition, divestiture and part - nership. If the existing headwinds do not materially worsen, M&A participants are likely to adapt rather than retreat. In that environment, the most successful deal-makers will be the ones that underwrite uncer - tainty clearly, allocate risk precisely and stay prepared to move when quality opportunities come to market.
1422 CHAMBERS.COM
Powered by FlippingBook